The H-FABP ≥ 0.2 ng/mL group showed higher SBP, prior stroke rate, and PA and also higher values in most of the cardio-specific biomarkers including CK-MB, NT-proBNP, TnI, myoglobin, cystatin-C and sST2 (p < 0.05) (Table 16). This evidence concerns the gene CST3 and stroke disorder.